PhotoCure ASA
(FRA:PHS)
€
5.23
-0.070 (-1.32%)
Market Cap: 142.18 Mil
Enterprise Value: 122.14 Mil
PE Ratio: 18.87
PB Ratio: 2.73
GF Score: 73/100 Q4 2021 Photocure ASA Earnings Presentation Transcript
Feb 23, 2022 / 01:00PM GMT
Release Date Price:
€9
(-3.02%)
Daniel Schneider
Photocure ASA - President & CEO
All right. Good day, everyone, and welcome to Photocure's Results for Fourth Quarter 2021. Joining me today is Erik Dahl. I am Dan Scheider, CEO of Photocure.
Next slide, a reminder for today's presentation, disclaimers are in place.
Next slide. The fourth quarter highlights. Exciting, I think. We had 10% organic growth adjusted for onetime sales benefit last year from the reversal of Medicare 340b accrual and for the negative foreign currency. We actually delivered this 10% revenue growth year-over-year. But most importantly, unit growth in the U.S. was 10% and Europe 11% and 12% segments respectively year-over-year. So 11% U.S., 12% unit growth in Europe. EBITDA was negative NOK 5.5
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot